Skip to main content

Drug information, misinformation, and disinformation on social media: a content analysis study


Dissemination of misleading drug information through social media can be detrimental to the health of the public. This study, carried out in Bahrain, evaluated the truthfulness of 22 social media claims about drugs (72.7%), dietary supplements (22.7%), and toxic bisphenol-A (4.5%). They circulated on WhatsApp platform, as case studies. We categorized claims as objectively true, false, or potentially misleading. The content analysis revealed that “potentially misleading” claims were the most frequent messages (59.1%). They tend to exaggerate the efficacy or safety without sufficient evidence to substantiate claims. False claims (27.3%) were likely due to unfair competition or deception. Overall, 13.6% of the messages were objectively true claims that could withstand regulatory scrutiny. Majority of the drug-related messages on social media were potentially misleading or false claims that lacked credible evidence to support them. In the public interest, regulatory authorities should monitor such information disseminated via social media platforms.

This is a preview of subscription content, access via your institution.


  1. Kaplan AM, Haenlein M. Users of the world, unite! The challenges and opportunities of social media. Bus Horiz. 2010;53:59–68.

    Article  Google Scholar 

  2. Kaplan AM, Haenlein M. Social media: back to the roots and back to the future. J Systems Inform. 2012;14:101–4.

    Google Scholar 

  3. von Muhlen M, Ohno-Machado L. Reviewing social media use by clinicians. J Am Med Inform Assoc. 2012.

    Google Scholar 

  4. Ventola CL. Social media and health care professionals: benefits, risks, and best practices. Pharm Ther. 2014;39(7):491–520.

    Google Scholar 

  5. Househ M. The use of social media in healthcare: organizational, clinical, and patient perspectives. In: Courtney KL, et al., editors. Enabling health and healthcare through ICT. Clifton: IOS Press; 2013.

    Google Scholar 

  6. Dumas A-A, Lapointe A, Desroches S. Users, uses, and effects of social media in dietetic practice: scoping review of the quantitative and qualitative evidence. J Med Internet Res. 2018;20:e55.

    Article  Google Scholar 

  7. Moorhead SA, Hazlett DE, Harrison L, Carroll JK, Irwin A, Hoving C. A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res. 2013.

    Google Scholar 

  8. De Martino I, D’Apolito R, McLawhorn AS, Fehring KA, Sculco PK, Gasparini G. Social media for patients: benefits and drawbacks. Curr Rev Musculoskelet Med. 2017.

    Google Scholar 

  9. Guidance for Industry. Internet/social media platforms: correcting independent third-party misinformation about prescription drugs and medical devices. Accessed 14 March 2018.

  10. Gutierrez MA, Moreno RA, Rebelo MS. Information and communication technologies and global health challenges global health informatics. In: Marin H, Massad E, Gutierrez MA, Rodrigues RJ, Sigulem D, editors. How information technology can change our lives in a globalized world. London: Academic Press; 2017. p. 77–83.

    Google Scholar 

  11. Bouhnik D, Deshen M. WhatsApp goes to school: mobile instant messaging between teachers and students. JITE Res. 2014;13:217–31.

    Article  Google Scholar 

  12. Preston I. The tangled web they weave: truth, falsity, & advertisers. Madison: The University of Wisconsin Press; 1994.

    Google Scholar 

  13. Faerber AE, Kreling DH. Content analysis of false and misleading claims in television advertising for prescription and nonprescription drugs. J Gen Intern Med. 2014.

    Google Scholar 

  14. EMA’s Pharmacovigilance Risk Assessment Committee (PRAC). PRAC concludes that diabetes medicine canagliflozin may contribute to risk of toe amputation. EMA/76661/201. (2017). Accessed 15 Oct 2017.

  15. WHO. Guidelines for the screening, care and treatment of persons with hepatitis C infection. (2014). Accessed 12 Oct 2017.

  16. U.S. Food and Drug Administration Graviola Group. (2014). Accessed 15 Oct 2017.

  17. U.S. Food and Drug Administration. Qualified Health Claims: Letter of Enforcement Discretion - Chromium Picolinate and Insulin Resistance (Docket No. 2004Q-0144)., Accessed 19 March 2018.

  18. U.S. Food and Drug Administration. FDA approved l-glutamine powder for the treatment of sickle cell disease. Accessed 19 March 2018.

  19. Myths and Realities - Facts about BPA. Accessed 19 March 2018.

  20. Centers for Disease Control and Prevention. CDC 24/7: saving lives. Protecting people. National Biomonitoring Program. Bisphenol A (BPA). Accessed 19 March 2018.

  21. Hormann AM, Vom Saal FS, Nagel SC, Stahlhut RW, Moyer CL, Ellersieck MR, et al. Holding thermal receipt paper and eating food after using hand sanitizer results in high serum bioactive and urine total levels of bisphenol-A (BPA). PLoS ONE. 2014;9(10):e110509.

    Article  Google Scholar 

  22. Losee RM. A discipline independent definition of information. J Am Soc Inf Sci. (1997). Accessed 19 March 2018.

  23. Zhou L. Automating linguistics-based cues for detecting deception in text-based synchronous computer-mediated communication. Group Decis Negot. 2004;13:81–106.

    Article  Google Scholar 

  24. Buckland M. Information as thing. J Am Soc Inf Sci. (1991). Accessed 19 March 2018.

  25. Garner SD. High-level colloquium on information literacy and lifelong learning. (2005). Accessed 19 March 2018.

  26. Karlova NA, Fisher KE. A social diffusion model of misinformation and disinformation for understanding human information behaviour. (2013). Accessed 18 March 2018.

  27. Aikin KJ, Southwell BG, Paquin RS, Rupert DJ, O’Donoghue AC, Betts KR, et al. Correction of misleading information in prescription drug television advertising: the roles of advertisement similarity and time delay. Res Soc Admin Pharm. 2017.

    Google Scholar 

  28. O’Donoghue AC, Williams PA, Sullivan HW, Boudewyns V, Squire C, Willoughby JF. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall. Soc Sci Med. 2014.

    Google Scholar 

  29. Australian Competition & Consumer Commission (ACCC). Full federal court orders $6 million penalty for Nurofen specific pain products. (2016). Accessed 19 March 2018.

  30. Xiao Q, Bertino E. Detecting deceptive engagement in social media by temporal pattern analysis of user behaviors: a survey. Wiley Interdiscip Rev Data Min Knowl Discov. 2017;7(5):e1210.

    Article  Google Scholar 

  31. Ahmed H, Traore I, Saad S. Detection of online fake news using N-gram analysis and machine learning techniques. LNCS. Cham: Springer; 2017. p. 127–38.

    Google Scholar 

  32. Fake News Challenge [Internet]. (2018). Accessed 19 March 2018.

  33. Guidance for Industry. Medical Product Communications that are consistent with the FDA-required-labeling-questions and answers. Accessed 19 March, 2018.

  34. Karapanos E, Teixeira P, Gouveia R. Need fulfillment and experiences on social media: A case on Facebook and WhatsApp. Comput Human Behav. 2016;55:888–97.

    Article  Google Scholar 

Download references


We acknowledge Ms. Mini James who has been of immense help in preparing the manuscript.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Khalid A. J. Al Khaja.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Al Khaja, K.A.J., AlKhaja, A.K. & Sequeira, R.P. Drug information, misinformation, and disinformation on social media: a content analysis study. J Public Health Pol 39, 343–357 (2018).

Download citation

  • Published:

  • Issue Date:

  • DOI:


  • Drug-related claims
  • Social media
  • Evidence base
  • Public
  • Bahrain
  • Independent third-party misinformation
  • User-generated content